XcellaraHeart
XcellaraHeart is an unverified brand name for which no reliable commercial evidence was found.
Last updated October 30, 2026
AI crawler reads
2requests
1companies- Anthropic2
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
No reliable evidence was supplied that identifies XcellaraHeart as a commercial brand, company, product platform, retailer, or trademarked offering. The two evidence items provided are unrelated to this name: one is a CBC News report about a defamation lawsuit filed by Montreal's former anti-racism commissioner, and the other is a CBC News 'About' page describing the publicly owned Canadian news service. Neither mentions XcellaraHeart, and neither can support claims about its products, ownership, headquarters, founding, or market positioning. Because the name could not be tied to any verifiable commercial entity, this entry is intentionally kept short and flagged for review. It should not be treated as a confirmed brand record, and no industry classification has been assigned. If a genuine official website, trademark filing, corporate registry record, or product listing for XcellaraHeart becomes available, this dossier should be rebuilt from that primary evidence.
Recent events
Reported
BioAdaptives launches XcellaraHeart cardiovascular supplement[3]
BioAdaptives, Inc. announced the commercial launch and pre-order availability of XcellaraHeart, a pharmaceutical-grade daily cardiovascular supplement and flagship product of its new Xcellara cellular wellness platform. The product is priced at $159.95 per bottle with a 30-day money-back guarantee and free U.S. shipping, with the first commercial batch scheduled to ship on August 26, 2026.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/xcellaraheart · Editorial policy · How profiles are compiled